Merck & Co., Inc. (MRK)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
FV Performance
FV Accuracy
15 Hits (214.29% Hit Rate)
FV Avg. Distance
-0.73%
FV Accuracy
22 Hits (183.33% Hit Rate)
FV Avg. Distance
-0.13%
FV Accuracy
22 Hits (115.79% Hit Rate)
FV Avg. Distance
-0.13%
FV Accuracy
22 Hits (51.16% Hit Rate)
FV Avg. Distance
+6.52%
About
CEO
Kenneth C. Frazier
Employees
71,000
Industry
Diversified Biopharmaceuticals
Sector
Healthcare
Headquarters
Kenilworth
Exchange
New York Stock Exchange
Website
http://www.merck.comSummary Stats
Market Cap
268B
Revenue
59.3B
Net Income
14.5B
EPS
$5.71
Price-to-Earnings
18.48
Price-to-Book
5.83
Debt-to-Equity
1.37
News
Analyst Ratings
Price targets projected by 19 analysts
High
$107.00
Average
$95.89
Low
$85.00
Ratings calculated by 22 analysts
Buy
17
Hold
5
Sell
0
Last Dividend
Amount
$0.73
Dividend Date
Frequency
quarterly
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q4 2022
Above by $0.08
$1.62 +5.2%
1.54
1.8
Down 10%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--